ZIOPHARM Oncology (ZIOP), a New York-based biotech, is up 24 cents to $7.80 and one investor pays 65 cents for the July 7 – 8 call spread, 1150X, and might roll a position up in strike prices. Separately, the July 8-Oct 8 call spread is being sold, 2075X at 25 cents. Looks like an opening reverse calendar spread. The positioning in ZIOP comes ahead of presentation tomorrow at a Deutsche Bank Securities Health Conference. Earnings could come into play soon as well. The company last reported on March 1.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.